Assessment of Oxygenation With Oxygen Reserve Index for General Anesthesia
1 other identifier
observational
2
1 country
1
Brief Summary
To assess oxygenation with the oxygen reserve index in desflurane anesthesia administration using low and high fresh gas flows for tympanomastoidectomy surgeries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2020
CompletedFirst Submitted
Initial submission to the registry
January 4, 2021
CompletedFirst Posted
Study publicly available on registry
January 7, 2021
CompletedJanuary 12, 2021
January 1, 2021
12 months
January 4, 2021
January 8, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
to assess oxygenation with the oxygen reserve index (ORI) in different fresh gas flows in general anesthesia.
to assess oxygenation with the oxygen reserve index (ORI) in desflurane anesthesia administration using low and high fresh gas flows for tympanomastoidectomy surgeries.
During the surgery procedure
Study Arms (2)
high flow rate
After intubation, patients had fresh gas flow with 50% O2/50% air for the first 10 minutes (3/3 L/min) and 6% desflurane. Then the flow rate was set to 4 L/min for Group High flow rate.
low flow rate
After intubation, patients had fresh gas flow with 50% O2/50% air for the first 10 minutes (3/3 L/min) and 6% desflurane. Then the flow rate was set to 1 L/min for Group Low flow rate.
Interventions
Eligibility Criteria
Aged between 18-65 years undergoing tympanomastoidectomy surgery
You may qualify if:
- American Society of Anesthesiologists (ASA) risk class I-II,
- Undergoing tympanomastoidectomy
You may not qualify if:
- Morbid obesity
- Opioid sensitivity Alcohol or drug addiction
- Chronic obstructive pulmonary disease
- Coronary artery disease,
- Congestive heart failure
- Pronounced anemia
- Have a history of liver or kidney disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zonguldak Bülent Ecevit University
Zonguldak, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
January 4, 2021
First Posted
January 7, 2021
Study Start
April 1, 2019
Primary Completion
March 30, 2020
Study Completion
March 30, 2020
Last Updated
January 12, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share